Sarizotan
Sarizotan (EMD 128130) is an orally active serotonin 5-HT1A receptor and dopamine receptor agonist. Sarizotan (EMD 128130) exhibits IC50 values of 6.5 nM (rat 5-HT1A), 0.1 nM (human 5-HT1A), 15.1 nM (rat D2), 17 nM (human D2), 6.8 nM (human D3) and 2.4 nM (human D4.2), respectively[1].
Product Specifications
CAS Number
351862-32-3
Product Name Alternative
EMD 128130
UNSPSC
12352005
Target
5-HT Receptor; Dopamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/sarizotan.html
Purity
98.23
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC1=CC=C(C2=CN=CC(CNC[C@H]3CCC4=CC=CC=C4O3)=C2)C=C1
Molecular Formula
C22H21FN2O
Molecular Weight
348.41
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
5-HT1 Receptor; D2 Receptor; D3 Receptor; D4 Receptor; lactoferrin; mLAG-3; MUC2; MUC3; Prostaglandin D Synthase; α-1 microglobulin
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GATA-3 (Breast and Urothelial Marker) (GATA3/2446), CF488A conjugate, 0.1mg/mL
Ep-CAM / CD326 (Epithelial Marker) (rMOC-31), CF640R conjugate, 0.1mg/mL
